Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...

Average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19 in mid-2024 -- the lowest average recorded in a ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

The analysts expect launches of medicines including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy to help add $20 billion to the value of the market in a decade. After a fallow period ...

AS HOLIDAY TREATS GIVE WAY TO NEW YEAR’S RESOLUTIONS, the names of GLP-1 weight-loss drugs like Ozempic and Wegovy will be on millions of lips this January—in addition to any leftover fruitcake, ...

So, 100 pounds is just unbelievable," Buckmaster said. She credits most of her success to Wegovy, an FDA-approved medication, prescribed by her doctor. “My insurance company covers it with zero ...

The Phase I trial of the therapy with 20 healthy subjects indicated no drug-related serious adverse events. Credit: Mongkolchon Akesin/Shutterstock. SIGA Technologies has gained Japanese regulatory ...